Methylation Status of MTHFR Promoter and Oligozoospermia Risk: An Epigenetic Study and in Silico Analysis

Atefeh Rezaeian1,2, Mohammad Karimian3, Abasalt Hossienzadeh Colagar2

  • 1Department of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran.

Cell Journal
|April 30, 2020
PubMed
Abstract

Insights

Methylation of the MTHFR gene promoter may increase the risk of oligozoospermia. This preliminary study suggests a potential biomarker role for MTHFR promoter methylation in male infertility.

Area of Science:

  • Genetics
  • Reproductive Biology
  • Epigenetics

Background:

  • Oligozoospermia, characterized by low sperm count, is a major cause of male infertility.
  • Epigenetic modifications, such as DNA methylation, play a crucial role in gene regulation and can impact reproductive health.
  • The methylenetetrahydrofolate reductase (MTHFR) gene is vital for folate metabolism and DNA synthesis, processes critical for spermatogenesis.

Purpose of the Study:

  • To investigate the association between promoter methylation of the MTHFR gene and the risk of oligozoospermia.
  • To conduct an in silico analysis of the MTHFR promoter region to understand its regulatory elements.

Main Methods:

  • A case-control study involving semen samples from infertile men (cases) and healthy controls.
  • Methylation-specific polymerase chain reaction (PCR) was used to amplify the MTHFR promoter region.
  • Bioinformatics software was employed for in silico analysis of the MTHFR promoter.

Main Results:

  • Significant associations were found between CpG island promoter methylation of MTHFR and oligozoospermia.
  • In silico analysis revealed a nucleosome exclusion region, CGIs, PROSITE motifs, and transcription factor binding sites within the MTHFR promoter, suggesting regulatory roles in spermatogenesis.

Conclusions:

  • Promoter methylation of the MTHFR gene may represent a risk factor for oligozoospermia.
  • This study provides preliminary data suggesting MTHFR promoter methylation as a potential biomarker for increased susceptibility to oligozoospermia.
  • Further comprehensive studies are warranted to establish a definitive clinical conclusion.